Results 161 to 170 of about 507,475 (219)
ABSTRACT We conducted a controlled trial among 5626 early adolescent women vaccinated in 2007–2009 against human papillomavirus (HPV) types 16/18 to evaluate the impact of high‐intensity versus low‐intensity cervical screening, respectively at ages 22/25/28 and 28 years with squamous‐cell intraepithelial lesions (SILs) as the end‐point.
Matti Lehtinen +15 more
wiley +1 more source
ABSTRACT Gastrointestinal (GI) cancers, including esophageal (EC), gastric (GC), and colorectal cancer (CRC), impose a substantial global burden, with early detection remaining crucial for improving patient outcomes. The oral and gut microbiota are increasingly implicated in cancer development and hold promise as sources of non‐invasive biomarkers ...
Saidi Hu +12 more
wiley +1 more source
Correction: Pathogenic characteristics and factors associated with multidrug-resistant bacterial infections after perianal abscess surgery. [PDF]
Wang B +5 more
europepmc +1 more source
Invasive Cervical Cancers After an HPV‐Negative Test: Insights From HPV Testing Histories
ABSTRACT Human papillomavirus (HPV) testing is the primary method for cervical screening, and a negative HPV test is associated with a very low subsequent risk of invasive cancer. Nevertheless, some cervical cancers are diagnosed following an HPV‐negative test.
Sadaf Sakina Hassan +5 more
wiley +1 more source
Women's perceptions of changes following the intervention on the prevention of mistreatment in gynecology and obstetrics in Guinea. [PDF]
Sall AO +9 more
europepmc +1 more source
ABSTRACT Many cervical screening programmes rely on cytology for triage of high‐risk human papillomavirus (hrHPV) positive women. However, cytological triage has variable and often limited sensitivity, and its availability can be restricted in resource‐poor settings.
Laura Burney Ellis +9 more
wiley +1 more source
KAZALD1 upregulation predicts poor prognosis in epithelial ovarian cancer: Clinical validation and immune correlates. [PDF]
Zhao R, Hu Y, Wang J, Lu J, Du G.
europepmc +1 more source
ABSTRACT Medication taken for other reasons than for the treatment of malignant disease, termed concomitant medication, is known to affect outcomes when used with immune checkpoint inhibitor therapy and other oncological drugs. However, no research in humans has addressed the relationship between concomitant medications and efficacy of oncolytic ...
Santeri A. Pakola +20 more
wiley +1 more source
Retraction Note: A randomized prospective comparison of the needleless mini‑sling "hammock" and "U‑shape" configurations for management of stress urinary incontinence: 18 month follow‑up results. [PDF]
Dogan O +4 more
europepmc +1 more source

